Executive committee appointments at Sandoz

Going into the second half of 2024, Swiss generics and biosimilars major Sandoz (SIX: SDZ) has announcing some senior leadership changes.

Pierre Bourdage, Sandoz chief commercial officer (CCO) and a member of the executive committee, is unfortunately stepping down from his role for personal health reasons.

The company has appointed Rebecca Guntern, currently president Europe and a member of the executive committee, as the new CCO effective September 1, 2024. A Swiss national, Ms Guntern is a seasoned commercial leader, who has been with Sandoz for almost two decades. She has successfully led the European organization across more than 40 countries since 2020. Under her tenure, the company’s leading position in Europe has further strengthened, particularly in biosimilars.